The U.S. Court of Appeals for the Federal Circuit today ruled against Hologic (NSDQ:HOLX) in a patent spat with Minerva Surgical, upholding a ruling from the U.S. Patent Trial and Appeal Board that claims on a patent Hologic owns, related to detecting perforations in body cavities during ablation, are unpatentable as obvious. In the case, Minerva […]
Alafair Biosciences said yesterday that it raised over $7.2 million in a Series B/B-1 financing round. Funds raised in the round will support the accelerated commercialization of the the Austin, Texas-based company’s VersaWrap tendon protector, its initial product. Alafair said that it has already received FDA clearance for its VersaWrap device, which is indicated for […]
Tela Bio said yesterday that it won FDA 510(k) clearance for its Restella reconstructive bioscaffolds, now cleared for use in reinforcing soft tissue in patients requiring soft tissue repair or reinforcement during plastic or reconstructive procedures. The Malvern, Penn.-based company’s tech platform is based on interwoven polymer through layers of biologic tissue in a patented pattern […]
Varian Medical (NYSE:VAR) has won an approximately $7.1 million delivery order against a five-year basic ordering agreement to supply the U.S. Department of Defense with two linear accelerator systems, according to a recently released DoD posting. The deal comes through a one-year contract with no option periods, and was a competitive acquisition with two offers received […]
A Boston Scientific (NYSE:BSX) employee is facing “Ultimate Hell Week” for a new Irish reality television series that premiered this week, according to a County Tipperary report. In the series, dubbed “Special Forces: Ultimate Hell Week,” 24 civilians face an eight-day army style selection course designed by former members of the country’s special forces unit, the […]
Bardy Diagnostics said this week that it raised $35.5 million in a round of Series B financing. The round was led by River Cities Capital Funds and joined by newly invested HealthQuest Capital, Aperture Venture Partners, Aphelion Capital, Lumira Ventures and Rex Health Ventures. Existing investors SV Health Investors, Health Enterprise Partners and Ascension Ventures […]
AngioDynamics (NSDQ:ANGO) said yesterday that it won central Institutional Review Board approval to run a clinical study of its NanoKnife irreversible electroporation system seeking an indication for use in treating Stage III pancreatic cancer. The Lantham, N.Y.-based company said that the approval will accelerate its engagement with local IRBs and will hasten its DIRECT clinical study. […]
ViewRay (NSDQ:VRAY) said this week that it inked distribution deals in both Australia and Canada for its MRIdian MRI-guided radiation therapy system. The MRIdian system is designed to integrate full-time MR imaging, cobalt radiation delivery and software automation for cancer treatment throughout the body, the Cleveland, Ohio-based company said. In a release posted yesterday, ViewRay said […]
InVivo Therapeutics (NSDQ:NVIV) yesterday presented twelve-month results from the single-arm INSPIRE study of its neuro-spinal scaffold. The Cambridge, Mass.-based company’s neuro-spinal scaffold is a novel, biodegradable device designed to be surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve sprouting. Results from the trial were presented at the 2019 AANS Meeting in […]
Terumo (OTC:TRUMY;TYO:4543) subsidiary MicroVention today released results from the WEB-IT pivotal trial of its Web aneurysm embolization system. Results from the trial were published in the online edition of the Journal of NeuroInterventional Surgery, the Aliso Viejo, Calif.-based company said. The trial enrolled a total of 150 patients across 21 U.S. centers and six international centers, MicroVention said. […]
Cook Medical said today that it is releasing de-identified patient-level data from a clinical trial of its Zilver PTX peripheral paclitaxel-eluting stent. The move comes only a month after the FDA said that its preliminary review of long-term follow-up data found a “potentially concerning signal” of increased long-term mortality in people with peripheral artery disease […]
MassDevice Network
@MassDevice
LinkedIn
YouTube